The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase.EBI
Pfizer
Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding.EBI
Pfizer
Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones.EBI
Pfizer
Substituted 6,7-dihydroimidazo[1,2-a]purin-9(4H)-ones.EBI
TBA
Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics.EBI
Lead Gene
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthma.EBI
Celltech R&D
Synthesis and profile of SCH351591, a novel PDE4 inhibitor.EBI
Schering-Plough
8-Methoxyquinolines as PDE4 inhibitors.EBI
Schering-Plough
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.EBI
Celltech R&D
Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.EBI
Korea Institute of Science and Technology
Synthesis and biological evaluation of 2,5-dihydropyrazol.EBI
RhôNe-Poulenc Rorer
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma.EBI
Celltech-Chiroscience
Synthesis and structure-activity relationships of 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indoles: novel PDE4 inhibitors.EBI
Institut De Recherche Jouveinal-Parke Davis
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors.EBI
Janssen-Cilag
A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.EBI
Korea Institute of Science & Technology
Identification of purine inhibitors of phosphodiesterase 7 (PDE7).EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Quinazolines: combined type 3 and 4 phosphodiesterase inhibitors.EBI
Novartis Pharma
Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitors.EBI
Pfizer
1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma.EBI
Smithkline Beecham Pharmaceuticals
Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.EBI
RhôNe-Poulenc Rorer
Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors.EBI
Dipartimento Di Scienze Farmaceutiche, Firenze, Italy.